Aligned with the needs of the growing and increasingly complex field of oncology, Advarra’s Central Oncology Review (COR) service provides the robust human subject protections review that cancer research institutions expect. Advarra has experts who have pioneered therapeutically specialized central review in oncology, including programs involving specialized research such as gene transfer protocols and targeted therapies.

Reinforced by the ability and integrity of the research community’s preferred central IRB, Advarra’s COR service offers flexible services supported by a rigorous, high-quality research process. COR’s IRB membership includes clinician researchers with significant oncology experience, including members with experience working in an institutional setting.


  • Deep regulatory knowledge and consultative approach
  • IRB membership with clinical oncology expertise from esteemed cancer centers
  • Decades of central review leadership and unmatched regulatory track record


As you’d expect of Advarra, COR partners closely with institutions to navigate the latest developments in oncology research and human subject protections. COR acts as an extension of internal research programs, providing expertise and support.


Advarra’s COR IRB roster comprises distinguished oncologists and individuals from leading cancer institutions, with oncology nursing, pharmacy and pathology experience, as well as patient advocates.


COR maintains a transparent review process, offering access to documents and data in real time with the added ability to discuss issues with a dedicated support specialist. You’ll always know the status of your review.

Ready for Solutions That Are Altogether Better?

Tell us what you’d like Advarra to do for your research program.